Mefenamic Acid for Primary Dysmenorrhea in Adolescents
For adolescents ≥14 years with primary dysmenorrhea, use mefenamic acid 500 mg as an initial dose, followed by 250 mg every 6 hours starting with the onset of bleeding, for 2-3 days maximum. 1
Dosing Protocol
The FDA-approved regimen is straightforward:
- Initial dose: 500 mg at onset of menstrual bleeding and symptoms
- Maintenance: 250 mg every 6 hours as needed
- Duration: 2-3 days (should not exceed one week)
- Age restriction: Approved for patients ≥14 years only 1
This dosing is supported by clinical evidence showing mefenamic acid 500 mg three times daily for 5 days effectively stops bleeding within 7 days in contraceptive-related bleeding irregularities 2, and the same regimen demonstrates efficacy comparable to other NSAIDs for dysmenorrhea 3, 4.
Clinical Efficacy
Mefenamic acid provides complete relief of dysmenorrhea symptoms in approximately 88-90% of patients 5. It performs equivalently to:
- Ibuprofen 400 mg for pain relief 3
- Meloxicam 7.5-15 mg for symptom reduction 4
- Other NSAIDs in head-to-head comparisons 6, 7
The medication works by reducing prostaglandin synthesis, directly addressing the pathophysiology of primary dysmenorrhea rather than just masking pain.
Safety Considerations for Adolescents
Critical contraindications to screen for:
- Active gastrointestinal bleeding or ulcer disease
- Renal impairment (NSAIDs carry nephrotoxicity risk)
- Bleeding disorders or concurrent anticoagulation
- Known hypersensitivity to NSAIDs or aspirin
- Third trimester pregnancy (though unlikely in dysmenorrhea treatment)
Common pitfalls to avoid:
- Inadequate dosing: 86% of self-medicating women use subtherapeutic doses 8. Ensure patients understand the full 500 mg initial dose is necessary
- Prolonged use: Treatment should not exceed 2-3 days per cycle; extended use increases GI toxicity risk 1
- Starting too late: Initiate at the very onset of bleeding and symptoms for optimal efficacy 1
Gastrointestinal Protection
While the evidence shows mefenamic acid has higher GI adverse events compared to some alternatives (two-thirds of GI events in comparative studies) 4, short-term use for 2-3 days per month carries acceptable risk. For adolescents requiring prolonged NSAID therapy (>5-7 days), consider gastric protection, though this is rarely necessary for standard dysmenorrhea treatment 2.
When Mefenamic Acid Fails
If symptoms persist after appropriate dosing:
- Rule out secondary causes: Endometriosis, pelvic inflammatory disease, structural abnormalities
- Consider combination therapy: Mefenamic acid 250 mg + dicyclomine shows superior efficacy in moderate-to-severe dysmenorrhea 8
- Alternative NSAIDs: Ibuprofen 400 mg every 6 hours or naproxen 500 mg twice daily for 5-7 days 2
- Hormonal options: Low-dose combined oral contraceptives for 10-20 days if medically eligible 2
Practical Counseling Points
- Timing is everything: Start medication at the first sign of bleeding or cramping, not after pain becomes severe
- Food intake: Take with food to minimize GI upset
- Rescue analgesia: Acetaminophen 500-1000 mg can be added if needed without significant drug interactions 6
- Expected duration: Most patients need treatment for only 2-3 days per cycle 1
- Reassurance: This is short-term, targeted therapy with excellent safety profile when used appropriately
The evidence strongly supports mefenamic acid as first-line pharmacotherapy for adolescent primary dysmenorrhea, with the critical caveat that proper dosing and duration must be followed to optimize efficacy while minimizing risk.